ESR1 and prostate carcinoma: Their mechanisms of action include modulation of aryl hydrocarbon receptor (AHR) signaling, impact on estrogen receptor (ER)-dependent signaling in breast cancer cells, antagonism of the androgen receptor in prostate cancer, epigenetic regulation of gene expression and modulation of DNA methylation and histone modifications [156].